EPISODE · Mar 23, 2022 · 52 MIN
Routine Checkup: Non-Ordinary State Work - MDMA Therapy
from Sickboy
Dr. Anne Wagner is a clinical psychologist and treatment development researcher based in Toronto, Canada. She is also the founder of Remedy, a mental health innovation community, and Remedy Institute, Remedy’s home for research. This week Anne joins Jeremie and Taylor to discuss the latest research involving MDMA as a therapeutic in the world of psychology. Anne is the lead investigator of the pilot trial of Cognitive Processing Therapy (CPT) for PTSD + MDMA and the upcoming randomized trial of Cognitive Behavioral Conjoint Therapy for PTSD (CBCT) + MDMA, a couples therapy for PTSD. She is deeply committed to bridging the worlds of psychotherapy and non-ordinary states of consciousness, has a passion for its use for relational healing, and works to uplift the voices of women in the psychedelic world. *Join the post-episode conversation over on Discord! https://discord.gg/expeUDN
What this episode covers
Dr. Anne Wagner is a clinical psychologist and treatment development researcher based in Toronto, Canada. She is also the founder of Remedy, a mental health innovation community, and Remedy Institute, Remedy’s home for research. This week Anne joins Jeremie and Taylor to discuss the latest research involving MDMA as a therapeutic in the world of psychology. Anne is the lead investigator of the pilot trial of Cognitive Processing Therapy (CPT) for PTSD + MDMA and the upcoming randomized trial of Cognitive Behavioral Conjoint Therapy for PTSD (CBCT) + MDMA, a couples therapy for PTSD. She is deeply committed to bridging the worlds of psychotherapy and non-ordinary states of consciousness, has a passion for its use for relational healing, and works to uplift the voices of women in the psychedelic world. *Join the post-episode conversation over on Discord! https://discord.gg/expeUDN
NOW PLAYING
Routine Checkup: Non-Ordinary State Work - MDMA Therapy
No transcript for this episode yet
Similar Episodes
Sep 20, 2023 ·42m
Sep 15, 2023 ·30m
Aug 9, 2023 ·85m
Jul 12, 2023 ·35m
Jul 9, 2023 ·40m